Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CEO

Chief Operating Officer

SVP & Chief Financial Officer

SVP Chief Commercial Officer

Chief Financial Officer

Standard BioTools Inc., together with its subsidiaries, creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Standard BioTools Inc., together with its subsidiaries, creates, manufactures, and markets instruments, consumables, reagents, and softwar...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-08	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2024-04-05	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-04-05	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-04	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-04	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-03-18	Premium	acquired	Premium	Premium	Premium	-
2024-03-05	Premium	bought	Premium	Premium	Premium	-
2024-03-04	Premium	bought	Premium	Premium	Premium	-
2024-02-20	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-05	Premium	acquired	Premium	Premium	Premium	President & CEO
2023-10-20	Premium	acquired	Premium	Premium	Premium	-
2023-07-03	Premium	sold	Premium	Premium	Premium	-
2023-06-29	Premium	sold	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-

LAB - Standard BioTools Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for LAB